-
Michael P. McDermott, PhD
… and other muscle diseases, HIV-associated dementia, multiple sclerosis, and attention deficit-hyperactivity …
-
Anne Messer, PhD
… from protein structure to behavioral genetics, covering multiple neurological diseases. She is currently a principal …
-
Kalipada Pahan, PhD
… neurodegenerative disorders such as Parkinson’s disease, multiple sclerosis and Alzheimer’s disease. He has over 95 …
-
Peter Werner, PhD
… and neuroprotection in Parkinson’s disease and in multiple sclerosis. Other interests concern a link between … acid called glutamate. While inflammation is well known in multiple sclerosis, it is just emerging as a major player in …
-
Path to Prevention Platform Trial Information for Researchers
… of the neuronal alpha-synuclein disease integrated staging system (NSD-ISS) . NSD Stage 2B identifies individuals with … infrastructure to simultaneously or sequentially test multiple investigational products. Additionally, platform … pre-specified analyses are being conducted to examine multiple exploratory clinical outcome measures and …
-
Valerie Joers, PhD
… between immune cells in the peripheral and central nervous systems in age-related neurodegenerative disorders such as … provide therapeutic targets to treat the impaired immune system in Parkinson’s. She obtained her doctorate in …